Your browser doesn't support javascript.
loading
Brentuximab vedotin after autologous transplantation in pediatric patients with relapsed/refractory Hodgkin lymphoma.
Forlenza, Christopher J; Rosenzweig, Jaclyn; Mauguen, Audrey; Buhtoiarov, Ilia; Cuglievan, Branko; Dave, Hema; Deyell, Rebecca J; Flerlage, Jamie E; Franklin, Anna K; Krajewski, Jennifer; Leger, Kasey J; Marks, Lianna J; Norris, Robin E; Pacheco, Martha; Willen, Faye; Yan, Adam Paul; Harker-Murray, Paul D; Giulino-Roth, Lisa.
Afiliação
  • Forlenza CJ; Department of Pediatrics, Memorial Sloan Kettering Cancer Center, New York, NY.
  • Rosenzweig J; Department of Pediatrics, Memorial Sloan Kettering Cancer Center, New York, NY.
  • Mauguen A; Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY.
  • Buhtoiarov I; Department of Pediatric Hematology/Oncology & Bone Marrow Transplantation, Cleveland Clinic Children's, Cleveland, OH.
  • Cuglievan B; Division of Pediatric Hematology Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX.
  • Dave H; Program for Cell Enhancement and Technologies for Immunotherapy, Children's National Hospital and The George Washington University, Washington, DC.
  • Deyell RJ; Department of Pediatrics, University of British Columbia, Vancouver, BC, Canada.
  • Flerlage JE; Department of Oncology, St. Jude Children's Research Hospital, Memphis, TN.
  • Franklin AK; Center for Cancer and Blood Disorders, Children's Hospital Colorado, Aurora, CO.
  • Krajewski J; Hackensack University Medical Center, Hackensack, NJ.
  • Leger KJ; Department of Pediatrics, Seattle Children's Hospital, Seattle, WA.
  • Marks LJ; Stanford University School of Medicine, Palo Alto, CA.
  • Norris RE; Cancer & Blood Disorders Institute, Cincinnati Children's Hospital Medical Center, Cincinnati, OH.
  • Pacheco M; Department of Pediatrics, Pediatric Hematology-Oncology, University of Texas Southwestern Medical Center, Dallas, TX.
  • Willen F; Department of Pediatrics, Division of Hematology/Oncology, Nationwide Children's Hospital, Columbus, OH.
  • Yan AP; Hospital for Sick Children, University of Toronto, Toronto, ON, Canada.
  • Harker-Murray PD; Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Boston, MA.
  • Giulino-Roth L; Medical College of Wisconsin, Milwaukee, WI.
Blood Adv ; 7(13): 3225-3231, 2023 07 11.
Article em En | MEDLINE | ID: mdl-36897253
Assuntos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Doença de Hodgkin / Transplante de Células-Tronco Hematopoéticas Tipo de estudo: Observational_studies / Risk_factors_studies Limite: Adolescent / Adult / Child / Humans Idioma: En Revista: Blood Adv Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Doença de Hodgkin / Transplante de Células-Tronco Hematopoéticas Tipo de estudo: Observational_studies / Risk_factors_studies Limite: Adolescent / Adult / Child / Humans Idioma: En Revista: Blood Adv Ano de publicação: 2023 Tipo de documento: Article